The ex vivo study showed that siRNA-based TIFA protein expression silencing in PBMCs obtained from systemic hypertension or PAH patients resulted in a significant reduction of both IL-1β and TNF-α levels (Fig. 3A,B). Here, TNF is linked to pulmonary arterial hypertension.